Can anti-angiogenic drug improve prognosis in CDDP resistant cell of oral cancer?
| Project/Area Number |
24792208
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
ISHIBASHI Miki 大阪大学, 歯学研究科(研究院), 招聘教員 (40412051)
|
|---|
| Project Period (FY) |
2012-04-01 – 2014-03-31
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | 抗血管新生 / 口腔癌 / 抗がん剤耐性 |
|---|
| Research Abstract |
The aim of this study was to clarify the sensibility of anti-angiogenesis therapy in CDDP-resistant oral squamous cell carcinomas. Briefly, ANG-1, ANG-2, VEGF, CD31 were immunohistochemically examined in order to evaluate its correlation with 3 type of human oral squamous cell carcinoma cell lines. We did not find significant correlation immunohistochemically with ANG-1, ANG-2 between human oral squamous cell carcinomas and CDDP-resistant oral squamous cell carcinomas. The sensibility of chemoradiotherapy in human oral squamous cell carcinomas after chemo-radiotherapy depend on, suggesting the involvement of other factors.
|
Report
(3 results)
Research Products
(7 results)
